CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 50 of 223 entries

View as:

A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee

Phase: N/A Priority: Normal

NCT ID: NCT01207115 Org: User:

Start: 09/30/10 End: 05/31/11 Due: 05/31/12

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis

Phase: N/A Priority: Normal

NCT ID: NCT01382212 Org: User:

Start: 10/31/11 End: 04/30/15 Due: 04/30/16

Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection

Phase: N/A Priority: Normal

NCT ID: NCT01328158 Org: User:

Start: 06/30/11 End: 12/31/13 Due: 12/31/14

Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia

Phase: N/A Priority: Normal

NCT ID: NCT01320735 Org: User:

Start: 02/28/11 End: 05/31/14 Due: 05/31/15

A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients

Phase: N/A Priority: Normal

NCT ID: NCT01506947 Org: User:

Start: 05/10/12 End: 04/07/16 Due: 04/07/17

This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal

NCT ID: NCT01676935 Org: User:

Start: 08/31/12 End: 03/31/14 Due: 03/31/15

Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab

Phase: N/A Priority: Normal

NCT ID: NCT01282372 Org: User:

Start: 03/31/11 End: 07/31/14 Due: 07/31/15

A Study of ABT-652 in Combination With a Nonsteroidal Anti-Inflammatory Drug (NSAID) in Adults With Osteoarthritis Pain of the Knee

Phase: N/A Priority: Normal

NCT ID: NCT01444365 Org: User:

Start: 10/31/11 End: 04/30/12 Due: 04/30/13

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal

NCT ID: NCT01063816 Org: User:

Start: 01/31/10 End: 08/31/16 Due: 08/31/17

Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)

Phase: N/A Priority: Normal

NCT ID: NCT01383005 Org: User:

Start: 06/30/11 End: 12/31/11 Due: 12/31/12

Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab

Phase: N/A Priority: Normal

NCT ID: NCT01752855 Org: User:

Start: 12/31/12 End: 10/31/13 Due: 10/31/14

Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use

Phase: N/A Priority: Normal

NCT ID: NCT00775437 Org: User:

Start: 03/31/09 End: 03/31/13 Due: 03/31/14

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT01464827 Org: User:

Start: 10/31/11 End: 09/30/13 Due: 09/30/14

Efficacy and Safety of Adalimumab in Patients With Active Uveitis

Phase: N/A Priority: Normal

NCT ID: NCT01138657 Org: User:

Start: 08/31/10 End: 08/31/14 Due: 08/31/15

A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study

Phase: N/A Priority: Normal

NCT ID: NCT01773070 Org: User:

Start: 06/30/13 End: 10/31/16 Due: 10/31/17

Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

Phase: N/A Priority: Normal

NCT ID: NCT00763321 Org: User:

Start: 09/30/08 End: 04/30/09 Due: 04/30/10

A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT01162421 Org: User:

Start: 09/30/10 End: 07/31/15 Due: 07/31/16

Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis

Phase: N/A Priority: Normal

NCT ID: NCT00573794 Org: User:

Start: 11/28/07 End: 12/31/16 Due: 12/31/17

Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00360568 Org: User:

Start: 06/30/09 End: 10/31/12 Due: 10/31/13

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

Phase: N/A Priority: Normal

NCT ID: NCT00486538 Org: User:

Start: 06/30/07 End: 06/30/12 Due: 06/30/13

A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal

NCT ID: NCT01589432 Org: User:

Start: 04/30/12 End: 11/30/12 Due: 11/30/13

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain

Phase: N/A Priority: Normal

NCT ID: NCT01620528 Org: User:

Start: 05/22/12 End: 09/28/15 Due: 09/28/16

A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00878449 Org: User:

Start: 10/31/09 End: 07/31/11 Due: 07/31/12

A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT01678755 Org: User:

Start: 08/31/12 End: 03/31/14 Due: 03/31/15

An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females

Phase: N/A Priority: Normal

NCT ID: NCT01403038 Org: User:

Start: 06/30/11 End: 11/30/12 Due: 11/30/13

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee	NCT01207115	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2010-09-30	2011-05-31	2012-05-31	-	-	2025-07-14
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis	NCT01382212	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-10-31	2015-04-30	2016-04-30	-	-	2025-07-14
Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection	NCT01328158	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-06-30	2013-12-31	2014-12-31	-	-	2025-07-14
Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia	NCT01320735	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-02-28	2014-05-31	2015-05-31	-	-	2025-07-14
A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients	NCT01506947	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-05-10	2016-04-07	2017-04-07	-	-	2025-07-14
This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease	NCT01676935	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-08-31	2014-03-31	2015-03-31	-	-	2025-07-14
Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab	NCT01282372	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-03-31	2014-07-31	2015-07-31	-	-	2025-07-14
A Study of ABT-652 in Combination With a Nonsteroidal Anti-Inflammatory Drug (NSAID) in Adults With Osteoarthritis Pain of the Knee	NCT01444365	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-10-31	2012-04-30	2013-04-30	-	-	2025-07-14
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors	NCT01063816	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2010-01-31	2016-08-31	2017-08-31	-	-	2025-07-14
Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)	NCT01383005	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-06-30	2011-12-31	2012-12-31	-	-	2025-07-14
Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab	NCT01752855	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-12-31	2013-10-31	2014-10-31	-	-	2025-07-14
Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use	NCT00775437	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2009-03-31	2013-03-31	2014-03-31	-	-	2025-07-14
ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients	NCT01464827	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-10-31	2013-09-30	2014-09-30	-	-	2025-07-14
Efficacy and Safety of Adalimumab in Patients With Active Uveitis	NCT01138657	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2010-08-31	2014-08-31	2015-08-31	-	-	2025-07-14
A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study	NCT01773070	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2013-06-30	2016-10-31	2017-10-31	-	-	2025-07-14
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)	NCT00763321	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2008-09-30	2009-04-30	2010-04-30	-	-	2025-07-14
A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis	NCT01162421	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2010-09-30	2015-07-31	2016-07-31	-	-	2025-07-14
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis	NCT00573794	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2007-11-28	2016-12-31	2017-12-31	-	-	2025-07-14
Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects	NCT00360568	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2009-06-30	2012-10-31	2013-10-31	-	-	2025-07-14
Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib	NCT00486538	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2007-06-30	2012-06-30	2013-06-30	-	-	2025-07-14
A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy	NCT01589432	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-04-30	2012-11-30	2013-11-30	-	-	2025-07-14
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain	NCT01620528	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-05-22	2015-09-28	2016-09-28	-	-	2025-07-14
A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer	NCT00878449	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2009-10-31	2011-07-31	2012-07-31	-	-	2025-07-14
A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia	NCT01678755	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-08-31	2014-03-31	2015-03-31	-	-	2025-07-14
An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females	NCT01403038	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-06-30	2012-11-30	2013-11-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance